High-performance Liquid Chromatography Market is Anticipated To Generate Significant Revenues by 2030: Grand View Research Inc.

 High-performance Liquid Chromatography Market Growth & Trends

The global high-performance liquid chromatography market size is projected to reach USD 7.03 billion by 2030, expanding at a CAGR of 5.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rapid growth in pharmaceutical production, stringent regulatory norms for drug purity, and increasing adoption of high-performance liquid chromatography (HPLC) techniques for diagnostics and research purposes are driving the market.

HPLC is commonly used for the assessment of drug purity on an industrial scale. It also enables characterization of molecules being explored as potential new drug candidates. Demand for the technique is anticipated to grow due to its increasing applications in ensuring consistency and determination of dosage of active pharmaceutical ingredients. Furthermore, the technique holds significance in quality control testing for assuring the fulfillment of critical quality attributes in the pharmaceutical industry.

The technique is augmenting clinical diagnostic services due to the availability of improved stationary phase alternatives and multiple channel HPLC instruments that can aid in sequential analysis of patient samples. Such attributes are desirable for low- or moderate-throughput laboratories and enable faster turnaround times. Similarly, recent developments in column technologies are increasing the efficiency of HPLC operations and are likely to fuel the market growth. For instance, the advent of>2-µm superficially porous silica particles has led to improved HPLC operations at comparatively lower back-pressure and with the use of shorter columns.

Furthermore, companies involved in the market are launching new HPLC-based analyzers and systems for capitalizing on the expanding scope of applications for the technique. For instance, in June 2021, Trivitron Healthcare launched two new HPLC analyzers, NANO H5 & NANO H110, intended for the detection of HbA1c and Hb variants in less than three minutes.

In addition, the COVID-19 pandemic has accelerated the adoption of HPLC systems for the development of new therapeutics, vaccines, and reliable diagnostic methods for the disease. Furthermore, epidemiological applications of the technique for the characterization of viral proteins are expected to gain traction due to the emerging mutations of the SARS-CoV-2 virus. These factors are anticipated to positively affect the market growth.

Request a free sample copy or view report summary: High-performance Liquid Chromatography Market Report

High-performance Liquid Chromatography Market Report Highlights

• By product, the instruments segment held the largest revenue share of over 45.0% in 2021 due to the increasing availability of technologically advanced and integrated HPLC systems and detectors
• Based on application, the clinical research applications segment held the largest revenue share of over 35.0% in 2021 due to the growth in the number of clinical trials and research & development activities in recent years, coupled with high analytical specificity and short runtimes offered that are suitable for clinical research
• By end-user, pharmaceutical and biotechnology companies accounted for the largest share of over 40.0% in 2021. This can be attributed to the increasing adoption of the technique for determination of drug purity and stability and the superior detection capacities and selectivity offered when used with mass spectrometry
• North America dominated the global market in 2021 with over 30.0% share due to rapid growth in the pharmaceutical industry and presence of key players such as Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; and Bio-Rad Laboratories, Inc. in the region
• Asia Pacific is anticipated to grow at the fastest rate over the forecast period due to a high potential for clinical research and large-scale production of generics and biosimilars in the region, which can significantly boost the adoption of HPLC technique

Access Press Release@ https://www.grandviewresearch.com/press-release/global-high-performance-liquid-chromatography-market

High-performance Liquid Chromatography Market Segmentation

Grand View Research has segmented the global high-performance liquid chromatography market based on product, application, end-user, and region:

High-performance Liquid Chromatography Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments
  • HPLC Systems
  • Pumps
  • Detectors
  • Others
• Consumables& Accessories
  • Columns
    • Reverse-phase HPLC Columns
    • Normal-phase HPLC Columns
    • Ion Exchange HPLC Columns
    • Size Exclusion HPLC Columns
    • Other HPLC Columns
  • Filters
    • Vials
    • Tubes
    • Others
  • Software

High-performance Liquid Chromatography Application Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Research Applications
• Diagnostic Applications
• Forensic Applications
• Other Applications

High-performance Liquid Chromatography End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Others

High-performance Liquid Chromatography Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of High-performance Liquid Chromatography Market

• Waters Corporation
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• Shimadzu Corporation
• Sartorius AG
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Tosoh Bioscience GmbH
• Gilson, Inc.
• Danaher Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Location-based Entertainment Market is Estimated To Attain $24.76 Billion by 2030

 Location-based Entertainment Market Growth & Trends

The global location-based entertainment market size is projected to reach USD 24.76 billion in 2030 and is expected to expand at a compound annual growth rate (CAGR) of 28.8% from 2023 to 2030. The growth can be credited to increasing consumer expenditure on new and exciting adventure and leisure activities. Rising disposable incomes and changing lifestyle patterns are the major factors driving the demand for location-based entertainment (LBE).

The growth of the location-based entertainment market is being further driven by the introduction of technologies, such as Augmented Reality (AR), Virtual Reality (VR), and mixed reality. These location-based entertainment services combined with these technologies provide visitors with an immersive and real-life experience. The market players are offering VR attractions under one roof to attract more visitors. For instance, in 2022, Sandbox VR announced to enter the Colorado location at Park Meadows Mall to provide a socially immersive gaming experience that combines high-quality haptics and full-body motion capture to provide complete immersion.

Global Location-based Entertainment Market Report Scope   

Report Attribute	Details
Market size value in 2023	USD 4,209.7 million
Revenue forecast in 2030	USD 24,763.5 million
Growth rate	CAGR of 28.8% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

Various video game developers are entering into mergers and acquisitions with VR and LBE technology providers to increase their respective market shares. For instance, in February 2021, Vertigo Games, a VR publisher and game developer, acquired Springboard VR, a VR venue management software and content marketplace provider for LBE. The acquisition was aimed at offering operators access to VR content through Vertigo Games' Haze VR distribution platform and providing both game studios and operators with new tools and technology to expand their LBE business.

Request a free sample copy or view the report summary: Location-based Entertainment Market Report

Location-based Entertainment Market Report Highlights

• In terms of component, the hardware segment accounted for over 64.0% of the total revenue share in 2022 owing to the increased spending on VR headsets that can deliver high-end immersive experiences to consumers
• In terms of technology, the 3D segment accounted for the revenue share of nearly 43.0% in 2022 and is expected to continue dominating the market over the forecast period owing to the continued advances in 3D technology extended reality, which is substantially deployed at LBE sites
• In terms of end-use, the arcade studios segment is expected to witness a growth rate of around 31.0% from 2023 to 2030
• The Asia Pacific regional market is anticipated to register a CAGR of around 31.0% from 2023 to 2030

Access Press Release@ https://www.grandviewresearch.com/press-release/global-location-based-entertainment-market

Location-based Entertainment Market Segmentation

Grand View Research has segmented the global location-based entertainment based on component, end-use, technology, and region:

Location-based Entertainment Component Outlook (Revenue, USD Million, 2018 - 2030)

• Hardware
• Software

Location-based Entertainment Technology Outlook (Revenue, USD Million, 2018 - 2030)

• 2 Dimensional (2D)
• 3 Dimensional (3D)
• Cloud Merged Reality

Location-based Entertainment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Amusement Parks
• Arcade Studios
• 4D films

Location-based Entertainment Regional Scope (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• South America
  • Brazil
• Middle East & Africa

List of Key Players in the Location-based Entertainment Market

• 4Experience
• AEON Fantasy Co
• Barron Games International
• Bob’s Space Racers
• CamOnApp
• Cinepolis
• Disney Parks, Experience, and Products (The Walt Disney Company)
• E-Learning Studios
• Google LLC
• HQ Software
• HTC Corporation
• Huawei Technologies Co., Ltd.
• KidZania Operations S.A.R.L.
• Magic Leap Inc.
• Microsoft Corporation
• Niantic Inc.
• Overseas Chinese Town Enterprise Co. (OCT) Parks
• Regal Entertainment Group
• Samsung Electronics Co., Ltd.
• Six Flag Entertainment Corporation
• Springboard VR
• Universal Parks and Resorts
• VRstudios, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Custom Antibody Market to Incur Meteoric Growth During 2023 to 2030: Grand View Research Inc.

 Custom Antibody Market Growth & Trends

The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during the forecast period. This growth is attributed to the increasing fundraising by biotech startups for developing innovative products. Additionally, rising awareness of personalized diagnostic and therapeutic treatments in emerging markets is also a contributing factor to the growth of the custom antibody market.

Increasing investment by the players to expand their services in the development and production of antibodies is likely to support the growth of the market. For instance, Absolute Antibody Ltd. is into the services of custom antibody sequencing, expression, and engineering. In August 2022, the company announced the expansion of its manufacturing facility by increasing the lab space and investing in automated technology such as next-generation sequencing, purification, and expression. The expansion is expected to improve the production workflow for recombinant antibodies.

Custom Antibody Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 158.0 million
Revenue forecast in 2030	USD 301.7 million
Growth rate	CAGR of 9.7% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

Similarly, companies are also improving the application of custom antibodies. According to an article published in January 2023, MilliporeSigma is planning to develop new antibodies through its Cell Marque Tissue Diagnostics technology. The rabbit polyclonal antibody is customized to detect a type of glioma, ATRX. Gliomas account for 30% of tumors in the central nervous system. Through this antibody, the company is anticipated to expand its portfolio in neuropathology.   

Monetary support to academic and research institutions through grants from regulatory bodies and discount offers on services by companies are anticipated to enhance custom antibody discovery and research during the forecast period. For instance, Absolute antibody offers 10% off on custom services, while a similar discount is also offered by AltaBioscience for a limited time period. The discounts are expected to reduce the overall cost of production for researchers.

However, the high cost of producing custom monoclonal antibodies is expected to restrain the growth of the custom antibody market. The average estimated cost is around USD 6,000 to 15,000. The cost acts as a market entry barrier for various startups and emerging players. However, the cost can be reduced by developing reliable production reagents and techniques to avoid the upfront cost.

Request a free sample copy or view report summary: Custom Antibody Market Report

Custom Antibody Market Report Highlights

• By type, the monoclonal antibody segment is considered to be a relatively more mature and dominant segment than polyclonal in 2022. The increasing R&D investment by companies is expected to support the growth of the custom antibody market
• By service, the antibody development segment captured the majority of the custom antibody market share in 2022. The number and type of players in this service segment are greater than antibody production and fragmentation, which is contributing to the growth
• By source, the mice segment is estimated to be the fastest-growing during the forecast period. This is because mice are widely available lab animals and can be easily used for custom antibody production
• By application, infectious disease is considered the key segment with the largest market share in 2022, and this trend is likely to be maintained over the forecast period. This growth can be attributed to the emerging infectious diseases in developing countries
• By end-users, the academic and research institutions segment is estimated to be the fastest-growing segment, with the largest market share in 2022. The growth is attributed to the increasing grants and financial assistance from governments and companies
• North America has established a strong regional position in the market with 44.91% of the overall market share in 2022. The increasing incidence rate of cancer and high R&D expenditure are encouraging companies to undertake product development in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-custom-antibody-market

Custom Antibody Market Segmentation

Grand View Research has segmented the global custom antibody market based on type, service, source, application, end-user, and region.

Custom Antibody Type Outlook (Revenue, USD Million, 2018 - 2030)

• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Others

Custom Antibody Service Outlook (Revenue, USD Million, 2018 - 2030)

• Antibody Development
• Antibody Production & Purification
• Antibody Fragmentation & Labeling

Custom Antibody Source Outlook (Revenue, USD Million, 2018 - 2030)

• Mice
• Rabbit
• Others

Custom Antibody Application Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Infectious Diseases
• Neurology
• Stem cells
• Immunology
• Cardiovascular Diseases
• Others

Custom Antibody End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• CRO
• Hospitals And Clinics

Custom Antibody Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Custom Antibody Market

• Thermo Fisher Scientific Inc.
• Creative Diagnostics
• Abcam plc
• Bio-Rad Laboratories, Inc
• Kaneka Eurogentec S.A.
• YenZym Antibodies, LLC.
• Abmart
• Labcorp Drug Development
• LifeSpan BioSciences, Inc
• GenScript

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pediatric Medical Devices Market to Penetrate Untapped Regions During 2023 to 2030: Grand View Research Inc.

 Pediatric Medical Devices Market Growth & Trends

The global pediatric medical devices market size is expected to reach USD 51.9 billion by 2030, expanding at a CAGR of 7.8% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases among children such as asthma, cystic fibrosis, diabetes, epilepsy, and technological advancements in pediatric medical devices are the major growth-propelling factors for the market.

Pediatric medical devices diagnose or treat diseases from birth through adolescence. The Federal Food, Drug, and Cosmetic Act consist of pediatric patients aged 21 or younger at the time of the treatment. In the U.S., the commercialization and development of pediatric medical devices lag significantly behind the medical devices for adults. In the last few years, only 24% of lifesaving medical devices have been approved by the FDA that can be used for childcare, and the majority of its users are 12 years and above.

Pediatric Medical Devices Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 30.7 billion
Revenue forecast in 2030	USD 51.9 billion
Growth rate	CAGR of 7.8% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

The COVID-19 pandemic has put the medical device industry at the center with unparalleled demand for personal protective equipment, diagnostic tests, ventilators, and other critical medical supplies. However, the pediatric medical device industry is highly impacted by the substantial decrease in the number of surgeries, many of which are being canceled or postponed so that hospitals and clinics can focus their resources on treating COVID-19 patients. The reopening of manufacturing units and supply-chain is expected to grow the market of pediatric medical devices.

The development and design of pediatric medical devices continue to be an exciting field. There are only a few pediatric devices than adult devices in the market which is forcing pediatric professionals to suggest alternative ways of treating children using devices mainly made for adults. Pediatric medical devices cover a wide range of indications and risks associated with child care. It also helps to reduce disease burden and improve the quality of life for many children.

Various innovation competitions took place to support new and advanced pediatric medical devices. For instance, since 2013, the “Make Your Medical Device Pitch for Kids” international competition has focused on supporting and identifying innovations that will make a substantial improvement in pediatric care.

Request a free sample copy or view report summary: Pediatric Medical Devices Market Report

Pediatric Medical Devices Market Highlights

• The anesthesia and respiratory care devices segment is expected to showcase the fastest CAGR over the forecast period as it is a commonly used product among children
• In Vitro Diagnostic (IVD) Devices segment held the largest share as of 2022 owing to the accurate and error-free diagnostic through the product
• The pediatric clinics segment is expected to showcase lucrative CAGR over the forecast period as these clinics are especially focused on children’s care
• The hospitals held the largest share as of 2022 owing to the high number of patient admission in the hospitals

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pediatric-medical-devices-market

Pediatric Medical Devices Market Segmentation

Grand View Research has segmented the global pediatric medical devices market based on product, end-user, and region:

Pediatric Medical Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiology Devices
• In Vitro Diagnostic (IVD) Devices
• Diagnostic Imaging Devices
• Anesthesia & Respiratory Care Devices
• Neonatal ICU Devices
• Others

Pediatric Medical Devices End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Pediatric Clinics
• Ambulatory Surgery Centers
• Others

Pediatric Medical Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Pediatric Medical Devices Market

• TSE MEDICAL
• Ningbo David Medical Device Co. Ltd
• Hamilton Medical
• GE Healthcare
• Fritz Stephan GmbH
• Phoenix Medical Systems Pvt Ltd
• Novonate Inc.
• Trimpeks
• Atom Medical Corporation
• Abbott
• Medtronic PLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Protein Crystallization Market Forecast 2030 Top Companies, Trends and Growth Factors Details for Business Development

 Protein Crystallization Market Growth & Trends

The global protein crystallization market size is expected to reach USD 2.14 billion by 2030, registering a CAGR of 8.25% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising demand for protein-based therapeutics, increasing funding & investments in proteomics research, and technological advancements in crystallography techniques are the key factors driving the market. Furthermore, major pharmaceutical applications associated with crystallization such as drug development, formulation, purification & separation, and drug delivery are anticipated to further boost the market during the study period.

Increasing funding & investments by several pharmaceutical and biotechnological companies are enhancing the R&D activities of proteomics in drug development. For instance, in January 2022, Protai raised funding of USD 8.0 million to develop a proteomics-based platform. This platform enables the viewing of new layers of disease on the protein level to reshape the drug discovery and development process. Hence, increasing funding may boost R&D activities, which ultimately increases the demand for protein crystallization techniques.

Protein Crystallization Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 1.23 billion
Revenue forecast in 2030	USD 2.14 billion
Growth rate	CAGR of 8.25% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

The sudden outbreak of COVID-19 led to an upsurge in research and development activities to design vaccines and drugs. Hence, it was important for researchers to study the structure, function, and pathogenesis of the virus. The crystallization techniques help researchers to determine the structure of SARS-CoV-2 proteins for the development of novel vaccines to treat the disease. For instance, researchers at Serum Institute of India Pvt. Ltd. developed a COVOVAX protein recombinant vaccine for COVID-19. Thus, the COVID-19 pandemic had a positive impact on the market.

Moreover, an increasing number of individuals have been utilizing protein-based drugs owing to their advantages such as low toxicity, high potency & specificity, and high tolerance by the human body. In addition, major players in the market are entering into partnerships and collaborations to develop protein-based therapeutics at more affordable costs for patients. For instance, in January 2022, Amgen entered into collaboration with Generate Biomedicines to discover and develop proteins for five targets across multiple modalities and therapeutic areas. Thus, such initiatives are expected to drive the adoption of protein crystallization methods during the estimated timeframe.

Furthermore, protein crystallization may aid in the identification of potential treatments for multiple diseases, from muscular dystrophy to cancer. For instance, according to an article published on NASA in July 2022, as said by researchers at the Japan Aerospace Exploration Agency, protein crystal growth in space may slow the progression of muscular dystrophy by half and potentially double the life span of many patients. Hence, the increasing R&D activities on protein crystals can significantly fuel the market during the estimated timeframe.

On the other hand, the high cost of instruments may restrain the market during the forecast years. On average a cryo-electron microscope costs about USD six million to seven million and an additional investment has to be spent on the infrastructure and supporting equipment. Such high costs may not be affordable for small- and medium-sized laboratories, which hampers market growth to a certain extent. In addition, challenges associated with the formulation and delivery of protein therapeutics may limit the market to some extent. However, operating players in the market are continuously working on the development of affordable instruments for crystallization.

Request a free sample copy or view report summary: Protein Crystallization Market Report

Protein Crystallization Market Report Highlights

• The consumables product segment held the largest share of 67.17% in 2022, owing to the advanced consumable offerings by the key players, coupled with recurring revenues generated by them
• By technology, the X-ray crystallography segment accounted for the largest share of 53.42% in 2022. The large share is due to the benefits offered by X-ray crystallography techniques, such as the technology being relatively simple, cost-effective, offering better diffraction, reducing radiation damage to crystals, and the possibility of safe storage, transport, and reuse of crystals
• By end-user, the pharmaceutical and biotechnology companies segment dominated the market in 2022 with a share of 67.60%, owing to the potential application of the method in biologics formulation by decreasing the viscosity of proteins in the crystalline form to create a higher concentration of effective therapeutics
• North America held the largest market share of 35.71% in 2022. The large share can be attributed to the increased investments in private companies, government assistance, and favorable regulations

Access Press Release@ https://www.grandviewresearch.com/press-release/global-protein-crystallization-market

Protein Crystallization Market Segmentation

Grand View Research has segmented the global protein crystallization market based on the product, technology, end-user, and region:

Protein Crystallization Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments
  • Liquid Handling Instruments
  • Crystal Imaging Instruments
• Consumables
  • Reagents & Kits/Screens
  • Micro Plates
  • Others
• Software & Services

Protein Crystallization Technology Outlook (Revenue, USD Million, 2018 - 2030)

• X-ray Crystallography
• Cryo-electron Microscopy
• NMR Spectroscopy
• Others

Protein Crystallization End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes

Protein Crystallization Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Protein Crystallization Market

• Rigaku Corporation 
• FORMULATRIX
• METTLER TOLEDO
• Corning Incorporated
• Greiner Bio-One International GmbH
• HAMPTON RESEARCH CORP
• Jena Bioscience GmbH
• Bruker
• Creative Proteomics
• Molecular Dimensions

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-steroidal Anti-inflammatory Drugs Market to Witness a Pronounce Growth During 2022 – 2030: Grand View Research Inc.

 Non-steroidal Anti-inflammatory Drugs Market Growth & Trends

The global non-steroidal anti-inflammatory drugs market is expected to reach USD 31.29 billion by 2030, expanding at a CAGR of 5.36% during the forecast period, according to a new report by Grand View Research, Inc. Nonsteroidal anti-inflammatory drugs are drugs that are primarily used to relieve inflammation and pain, as well as to lower elevated body temperature. The high prescription rate of non-steroidal anti-inflammatory drugs (NSAIDs) for relief of symptoms of painful periods, headaches, fever, arthritis, sprains, strains, and other types of chronic pain is expected to drive the market during the forecast period.

The non-steroidal anti-inflammatory drugs market is expected to witness growth opportunities owing to factors such as the rising prevalence of targeted diseases and chronic pain across the globe, coupled with the high prevalence of these diseases in the geriatric population. Moreover, increasing demand for OTC NSAIDs and the rising adoption of NSAIDs for headaches, migraines, and menstrual pain are also expected to boost the growth during the forecast period. 

Non-steroidal Anti-inflammatory Drugs Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 20,486.56 million
Revenue forecast in 2030	USD 31,287.73 million
Growth rate	CAGR of 5.36% from 2022 to 2030
Base year for estimation	2021
Historical data	2018 - 2020
Forecast period	2022 - 2030

Moreover, the increasing prevalence of arthritis and other pain-related disorders is also expected to support the growth. For instance, the prevalence of osteoarthritis is higher in the UK, France, and Germany compared to other countries in the Europe region. The prevalence of arthritis is seen to be lower in people who are often engaged in physical activities, and its prevalence rises with age. Thus, the rising prevalence of arthritis is also expected to cater to the growth during the forecast period.

Key market players are adopting strategic initiatives such as geographical expansion and the introduction of combination non-steroidal anti-inflammatory drugs to increase their market share across the globe. For instance, Alkem Labs and Dr. Reddy’s Laboratories Ltd have launched their non-steroidal anti-inflammatory drugs in the U.S. Moreover, increasing approval of OTC drugs for pain management and other inflammatory diseases is expected to drive growth during the forecast period. Thus, owing to the various strategies adopted by key players, the market is likely to boost its growth.

Governments in various regions are undertaking favorable initiatives to reduce the burden of migraine, arthritis, and other diseases in their countries. For instance, the National Institutes of Health has initiated HEAL to accelerate research activities to improve the management of pain and inflammatory diseases. Moreover, the Patient-Centered Outcomes Research Institute has undertaken initiatives to introduce non-opioid treatment options for pain. Such initiatives are expected to increase growth during the forecast period. 

Request a free sample copy or view report summary: Non-steroidal Anti-inflammatory Drugs Market Report

Non-steroidal Anti-inflammatory Drugs Market Report Highlights

• In 2021, the arthritis segment dominated the NSAIDs market owing to the higher prevalence of arthritis across the globe
• The retail pharmacy segment held the largest share and is anticipated to maintain its dominance during the forecast period
• Asia Pacific region is expected to witness the highest CAGR during the forecast period owing to factors such as the high prevalence of pain and related disorders, the high pool of patients, and a rising geriatric population across the region
• North America dominated the market in 2021 due to the higher prevalence of arthritis, the presence of leading market players, and increased research activities within the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-non-steroidal-anti-inflammatory-drugs-market

Non-steroidal Anti-inflammatory Drugs Market Segmentation

Grand View Research has segmented the non-steroidal anti-inflammatory drugs market based on disease indication, route of administration, distribution channel, and region:

Non-steroidal Anti-inflammatory Drugs Disease Indication Outlook (Revenue, USD Million; 2018 - 2030)

• Arthritis
• Migraine
• Ophthalmic Diseases
• Others

Non-steroidal Anti-inflammatory Drugs Route of Administration Outlook (Revenue, USD Million; 2018 - 2030)

• Oral
• Topical
• Others

Non-steroidal Anti-inflammatory Drugs Distribution Channel Outlook (Revenue, USD Million; 2018 - 2030)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Non-steroidal Anti-inflammatory Drugs Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE

List of Key Players of Non-steroidal Anti-inflammatory Drugs Market

• Pfizer Inc.
• Bayer AG
• GSK plc
• Reddy’s Laboratories Ltd
• Viatris Inc
• Teva Pharmaceutical Industries Ltd.
• Johnson And Johnson Services, Inc.
• Merck & Co., Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Topical Drugs Market is Expected to Enhance USD 217.79 Billion Revenue By 2030: Grand View Research Inc.

 Topical Drugs Market Growth & Trends

The global topical drugs market size is expected to reach USD 217.79 billion by 2030, according to a new report by Grand View Research Inc. The industry is expected to grow at a CAGR of 10.1% from 2022 to 2030. The key factors contributing to the industry growth include the increased prevalence of skin disorders coupled with strategic collaborations between key players. The increasing prevalence of skin infections, such as psoriasis, atopic dermatitis, and eczema, coupled with the rising demand for eye and ear therapies is expected to drive the demand for transdermal or dermal medicines during the forecast period. For instance, in October 2021, AbbVie Inc. received FDA approval for Vuity, a pilocarpine HCl ophthalmic solution for treating presbyopia.

In addition, according to the NCBI, the prevalence of psoriasis is nearly 1.92% and 1.5% among European and North American populations. The launch of topical medicines to treat skin diseases is also anticipated to propel the demand for dermal drugs. For instance, in September 2020, Bausch Health, Canada launched a novel antipsoriatic agent, Duobrii lotion for psoriasis patients.Advancements in technology and increased acquisitions and mergers activities among key players, such as Alcon, Inc. and Novartis AG, are anticipated to boost the industry's growth. For instance, in June 2022, Novartis AG acquired Kedalion Therapeutics, thereby acquiring AcuStream technology to facilitate accurate dermal delivery of ophthalmic medicines.

Topical Drugs Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 100.92 billion
Revenue forecast in 2030	USD 217.79 billion
Growth rate	CAGR of 10.1% from 2022 to 2030
Base year for estimation	2021
Historical data	2018 - 2020
Forecast period	2022 - 2030

Moreover, in May 2022, Alcon Inc. acquired Eysuvis (loteprednol etabonate suspension) for topical ophthalmic use from Kala Pharmaceuticals, Inc., thereby adding to its existing portfolio of dry eye drugs.A high incidence of burn injuries is expected to render high utilization of topical medicines in treating burn injuries. For instance, according to the WHO, an estimated 11 million burn injuries occur annually worldwide, out of which about 180,000 cases are fatal. Various topical agents are used in treating burn injuries including silver sulfadiazine cream, bismuth-impregnated petroleum gauze, cerium nitrate, mafenide acetate, and nanocrystalline silver among others.

Request a free sample copy or view report summary: Topical Drugs Market Report

Topical Drugs Market Report Highlights

• The semi-solid formulations segment dominated the market in 2021 owing to their high stability in atmospheric conditions and increased use of personalized drugs
• The dermal segment dominated the industry in 2021 due to the increased utilization of transdermal patches to reduce tobaccoconsumption
• The home care settings segment dominated the industry in 2021 due to the ease of administration among the geriatric population
• North America was the largest regional market in 2021 due to strategic initiatives and collaborations among key players for the development & launch of dermal products

Access Press Release@ https://www.grandviewresearch.com/press-release/global-topical-drugs-market

Topical Drugs Market Segmentation

Grand View Research has segmented the global topical drugs market based on type, route of administration, end-use, and region:

Topical Drugs Type Outlook (Revenue, USD Million, 2018 - 2030)

• Semi-solid formulations
  • Creams
  • Ointments
  • Lotions
  • Gel
  • Pastes
• Liquid Formulations
  • Suspensions
  • Solutions
• Solid Formulations
  • Powders
  • Suppositories
• Transdermal Products
  • Transdermal Patches
  • Transdermal Semi-solids

Topical Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery

Topical Drugs End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Home Care Settings
• Hospitals & Clinics
• Burn Centers
• Other Facilities

Topical Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Topical Drugs Market

• Bayer AG
• Cipla Inc.
• GSK Group of Companies
• Johnson & Johnson Private Ltd.
• Novartis AG
• Bausch Health Companies Inc.
• HisamitsuPharmaceuticals Co. Inc.
• Merck & Co. Inc.
• Glenmark Pharmaceuticals Ltd.
• MedPharm Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Dog Dewormers Market Expectations Acme Prominent Development in Developed Regions, Details Gvr Study

 Europe Dog Dewormers Market Growth & Trends

The Europe dog dewormers market size is expected to reach USD 864.18 million by 2030, expanding at a CAGR of 10.67% over the forecast period, according to a new report by Grand View Research, Inc. Rising canine population coupled with their ownership and growing expenditure on dogs are major drivers propelling the market growth. FEDIAF’s 2022 report indicated that Europe’s pet-owning households reached 90 million (i.e. 46%) in 2021, and among these households live approximately 92.9 million dogs. Furthermore, the European population spends around USD 24.5 Billion on pet-related services and products each year, according to European Pet Food Industry. Similarly, according to data published by N26 GmbH in October 2020, around USD 15.8 to USD 52.8 (EUR 15-50) per month is spent on dog insurance, depending on their breed.

Various government organizations in Europe were actively monitoring the impact of COVID-19 on veterinary medicines supply chains. As per FVE (Federation of Veterinarians of Europe) in July 2021, veterinary services for companion animals in the region have been highly impacted during the mid of 2020, as only emergency and urgent treatments were allowed as per the government regulations. However, veterinary businesses quickly recovered with the support of e-commerce sales channels and the implementation of enormous government initiatives to continue veterinary healthcare practices.

Europe Dog Dewormers Market Report Scope

Report Attribute	Details
The market size value in 2023	USD 424.90 million
The revenue forecast in 2030	USD 864.18 million
Growth rate	CAGR of 10.67% from 2023 to 2030
Base year for estimation	2022
Historical data	2018 - 2021
Forecast period	2023 - 2030

For instance, in March 2020, FVE stated that veterinary services in Europe are considered one of the most essential businesses and will be continuing despite the ongoing pandemic. Veterinarians, vet clinics, and key market players have implemented various strategies to revive their services. Countries like the U.K. and France, have shifted towards digital vet consultations for essential pet care and proceeding with the online supply of dog dewormer products.

The Europe dog dewormers industry is expected to grow notably in the coming years. This can be attributed to the well-established veterinary care infrastructure, a large dog population, and the local presence of key companies. According to the annual report of FEDIAF 2022 (the European Pet Food Industry), the countries like Russia, the U.K., Germany, Spain, France, and Italy were registered to have households owning more than 7 million dogs.

The market is reasonably competitive. The most notable participants in the market include Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva, Sava Healthcare, Beaphar, and Bob Martin, among others. These players are involved in acquisitions, new product launches, collaborations, geographical expansions, and partnerships to gain a competitive edge over each other. In January 2021, Boehringer Ingelheim International GmbH announced marketing authorization approval in Europe for NexGard products, which are used as antiparasitics in dogs and cats. The approval was granted by European Medicines Agency (EMA) and European Commission.

Request a free sample copy or view report summary: Europe Dog Dewormers Market Report

Europe Dog Dewormers Market Report Highlights

• Rising disposable income, growing adoption of pets, and rising pet expenditure are expected to fuel the market growth during the forecast period. The recent COVID-19 pandemic has increased the pet adoption rate significantly, owing to the rise in the average hours people spend in households. For instance, the U.K. witnessed an ever-rising pet adoption rate, leading to emptied shelters during the pandemic
• In terms of revenue, the veterinary clinics dominated the distribution channel segment with a share of around 38% in 2022 owing to the increasing number of veterinary clinic establishments and rising veterinarian employment
• The U.K. is anticipated to account for the largest market share of around 14% owing to the presence of major market players and the high dog population in the region
• Some key industry players include Elanco, Zoetis, Boehringer Ingelheim International GmbH, Virbac, and others

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-dog-dewormers-market-analysis

Europe Dog Dewormers Market Segmentation

Grand View Research has segmented the Europe dog dewormers market based on distribution channel and country:

Europe Dog Dewormers Distribution Channel (Revenue, USD Million, 2018 - 2030)

• Veterinary Clinics
• Retail/Pet Stores
• E-Commerce

Europe Dog Dewormers Country Outlook (Revenue, USD Million, 2018 - 2030)

• Spain
• Germany
• Portugal
• Romania
• Slovakia
• Czech
• Hungary
• Poland
• Italy
• Ireland
• UK.
• France
• Denmark
• Sweden
• Norway
• Rest of Europe

List of Key Players in the Europe Dog Dewormers Market

• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Virbac
• Elanco
• Ceva
• Zoetis
• PetIQ, LLC
• Sava Healthcare Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.